Neovacs S.Aの債務/株式
Neovacs S.Aの債務/株式は何ですか。
Neovacs S.A.の債務/株式は0.08です。
債務/株式の定義は何ですか。
負債比率は、株主資本と企業資産の融資に使用される負債の相対的割合を示す財務比率です。
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
EURONEXTのセクタHealth Careにおける債務/株式の企業と比べるNeovacs S.A
Neovacs S.Aは何をしますか。
Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.
Neovacs S.Aと類似の債務/株式
- Invex Therapeutics Ltdの債務/株式は0.08です。
- Engineer Gold Minesの債務/株式は0.08です。
- Bajaj & Investmentの債務/株式は0.08です。
- Little Fish Acquisition Iの債務/株式は0.08です。
- Yatra Capitalの債務/株式は0.08です。
- AIA Engineeringの債務/株式は0.08です。
- Neovacs S.Aの債務/株式は0.08です。
- Kestrel Goldの債務/株式は0.08です。
- Sherpa IIの債務/株式は0.08です。
- Appulseの債務/株式は0.08です。
- Alphawave IP plcの債務/株式は0.08です。
- Jessy Venturesの債務/株式は0.08です。
- OD6 Metalsの債務/株式は0.08です。